Global Financial Private Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-839
Closed -$201K 399
2019
Q3
$201K Sell
839
-33
-4% -$9.04K 0.01% 244
2019
Q2
$246K Sell
872
-3,407
-80% -$931K 0.01% 253
2019
Q1
$1.23M Buy
+4,279
New +$1.24M 0.06% 224
2018
Q4
Sell
-1,598
Closed -$438K 371
2018
Q3
$438K Buy
1,598
+79
+5% +$20.5K 0.02% 400
2018
Q2
$362K Buy
1,519
+15
+1% +$3.47K 0.01% 425
2018
Q1
$330K Buy
+1,504
New +$353K 0.01% 428
2017
Q4
Sell
-1,348
Closed -$256K 539
2017
Q3
$256K Buy
+1,348
New +$257K 0.01% 421

Other funds holding ELV

Global Financial Private Capital's ELV Position: Q4 2019 in Review

Global Financial Private Capital sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 839 shares — an estimated $201K sold.

Global Financial Private Capital first reported a position in ELV in Q3 2017 and held it in 7 quarters. The position peaked at $1.23M in Q1 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Global Financial Private Capital reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
  • Global Financial Private Capital sold 839 Elevance Health shares in Q4 2019, an estimated $201K.
  • Global Financial Private Capital first reported a position in Elevance Health in Q3 2017 and held it in 7 quarters.
  • Global Financial Private Capital's Elevance Health position peaked at $1.23M in Q1 2019.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Global Financial Private Capital's 13F filing for Q4 2019, filed 11 Feb 2020.